These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 5633100)
41. [Hypothyroidism due to therapy of Basedow's disease with radioiodine]. Giustina G; Valentini F; Cantalamessa L; Reschini E; Lodeserto A Folia Endocrinol; 1966 Feb; 19(1):34-47. PubMed ID: 5953703 [No Abstract] [Full Text] [Related]
42. [Goiters absorbent of iodine. Etiologic aspects]. Roger P J Med Bord; 1967 May; 144(5):747-53. PubMed ID: 5608060 [No Abstract] [Full Text] [Related]
43. [Basedow's disease and thrombopenic purpura. Apropos of a case of cure of both diseases with antithyroid treatment alone]. Mornex R; Revol L; Pousset G; Prost G Rev Fr Endocrinol Clin; 1971; 12(2):147-54. PubMed ID: 5171783 [No Abstract] [Full Text] [Related]
44. [Regulation of thrombocytopoiesis studied by a mathematical model]. Selivanov VA; Tiazhelova VG Tsitologiia; 1984 Mar; 26(3):348-52. PubMed ID: 6729997 [TBL] [Abstract][Full Text] [Related]
45. Observations on the course of exophthalmos after 131-I therapy. Jones DI; Munro DS; Wilson GM Proc R Soc Med; 1969 Jan; 62(1):15-8. PubMed ID: 5818231 [No Abstract] [Full Text] [Related]
46. [Treatment of patients with toxic diffuse goiter]. Spesivtseva VG Klin Med (Mosk); 1983 Oct; 61(10):118-23. PubMed ID: 6417398 [No Abstract] [Full Text] [Related]
47. I-131 treatment for toxic diffuse goiter. Analysis of 594 cases treated with repeated doses of 7 millicuries or less. Yang HF Taiwan Yi Xue Hui Za Zhi; 1971 Feb; 70(2):103-11. PubMed ID: 5281463 [No Abstract] [Full Text] [Related]
48. The significance and distinct interactions of various growth factors in physiologic and pathologic megakaryocytopoiesis/thrombocytopoiesis. Haznedaroglu IC; Gullu IH; Dundar S; Kirazli S Aust N Z J Med; 1997 Apr; 27(2):191-2. PubMed ID: 9145189 [No Abstract] [Full Text] [Related]
55. Stimulation of thrombocytopoiesis in irradiated mice. Ebbe S; Stohlman F Blood; 1970 Jun; 35(6):783-92. PubMed ID: 5427248 [No Abstract] [Full Text] [Related]
56. [Current approaches to the treatment of diffuse toxic goiter]. Balabolkin MI Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095 [No Abstract] [Full Text] [Related]
57. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter. Burgos FL; Micames C; Rivera JV Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791 [No Abstract] [Full Text] [Related]
58. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA; Daykin J; Holder R; Sheppard MC QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667 [TBL] [Abstract][Full Text] [Related]
59. [Surgical treatment of recurrent goiter]. Sedov VM; Sedletskiĭ IuI; Belianina EO Vestn Khir Im I I Grek; 1999; 158(5):53-6. PubMed ID: 10645583 [TBL] [Abstract][Full Text] [Related]
60. [Treatment with I-131 of postoperative relapses of diffuse toxic goiter]. Dozorets IuL; Perlin MS; Popova LI Med Radiol (Mosk); 1966 Nov; 11(11):11-4. PubMed ID: 5996574 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]